Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban vs Antiplatelet/No Treatment after ICH in AF
NCT02565693Phase 2Completed
- Start
- Sep 2014
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apixaban in Atrial fibrillation (AFib). Started Sep 2014; status: completed.
02
Drugs
apixaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02565693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02565693.